biopharmaceuticals based on immunology

History:

Sangstat was acquired by Genzyme in 2003. The Fremont facility will be shut down and all former Sangstat functions will be absorbed into Genzyme's Cambridge, MA facility.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northern California

Research Focus:
Disease Pharmaceutical

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: